Kimberly-Clark Corporation· KMB
🇺🇸 US · LargeSP500NASDAQ
- Price
- $97.86
- Day
- -0.34%
- Mkt Cap
- $32.48B
- 52W Range
- $92.42 – $125.32
- Volume
- 6.66M
- Beta
- 0.27
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Younger investors are rewriting the rules of wealth building, and five overlooked dividend stocks under $20 sit right at the center of that shift. The real question is whether these picks can hold up long enough to matter.
Read full article
Dividend Kings have a 50+ year track record of increasing dividends, showcasing resilience through economic challenges. I rank the Dividend Kings using my 9F Quality Scores, blending qualitative and quantitative factors for a robust, investment-grade assessment. ADP stands out as the best total-return candidate. It is undervalued, high-quality, and offering a strong projected dividend growth rate and Adjusted Chowder Number.
Read full article
Here are three durable businesses offering yields from 1.6% to 5.5%.
Read full article
KMB is tackling $150 million of second-half input-cost pressure with targeted pricing, productivity gains and supplier actions.
Read full article
Kenvue's dependable dividend is above average, and it could go even higher if the company is bought by Kimberly-Clark.
Read full article
Kimberly-Clark is readying concessions to address EU antitrust concerns about its bid for Tylenol maker Kenvue that could help it win approval for the $40 billion deal after a preliminary review, people familiar with the matter said.
Read full article
On CNBC's “Halftime Report Final Trades,” Kevin Simpson, founder and CEO of Capital Wealth Planning, picked Freeport-McMoRan Inc. (NYSE:FCX) amid the recent pullback in copper.
Read full article
Owning consumer staples stocks is an absolute must in a dividend investing strategy. Most people turn to dividend stocks for two reasons — to generate income or to put the magic of compounding to work using dividend reinvestment to amplify wealth building over time.
Read full article
Kimberly-Clark just raised its dividend for the 54th straight year while simultaneously chasing a nearly $50 billion acquisition, and income investors are now weighing whether a deal of that size can coexist with a payout that costs over $1.
Read full article
Kimberly-Clark produces paper products that are, effectively, life necessities. The company is planning to buy Kenvue, which makes over-the-counter healthcare items.
Read full article
KMB's North America business faces near-term shipment pressure, but innovation, share gains and easier comparisons support a stronger second half.
Read full article
Kimberly-Clark Corporation (KMB) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
Read full article